Literature DB >> 11190572

Smad transcriptional corepressors in TGF beta family signaling.

D Wotton1, J Massagué.   

Abstract

The known Smad transcriptional repressors appear to play multiple roles in modulating TGF beta-activated transcriptional responses. As detailed in Fig. 4, in the [figure: see text] absence of TGF beta signals, Ski/Sno prevent the activation of transcription by Smad proteins that find their way to the nucleus. Following TGF beta stimulation, the interaction with Ski/Sno is lost and these proteins are degraded. The free, activated Smad complex then enters the nucleus, where it can form two different kinds of transcriptional complexes: one involving interactions with general transcriptional coactivators, resulting in transcriptional activation, and the alternate complex, in which coactivators are displaced by a complex of corepressors recruited via a protein such as TGIF. The relative levels of these two complexes formed appear to be determined by the levels of available Smad coactivators and corepressors present within the cell. Once Smad transcriptional complexes have been formed, they can be further modulated by corepressors in at least two ways. TGF beta itself appears to upregulate SnoN expression, perhaps resulting in negative feedback on the activating Smad complexes. The balance between coactivators and corepressors within the cell can also be altered by other signaling inputs, and it appears that the stabilization of TGIF in response to activation of the MAP kinase pathway is able to shift the balance towards transcriptional repression. The scheme of action of Smad corepressors, represented in Fig. 4, is based on the initial analyses of these factors, and the challenge for the future is to more fully understand the precise physiological roles of Smad corepressors. Determining the roles they play in modulating responses to TGF beta family ligands during development, together with an analysis of the contributions of mutations that affect Smad corepressor function to genetic diseases such as HPE and to cancer will also be of great interest. Additionally, a better understanding of the events within the nucleus following BMP signaling may reveal the presence not only of more BMP-specific Smad recruiters, but also of BMP Smad-specific corepressors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11190572

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  43 in total

Review 1.  TGF-beta-mediated control of allergen-specific T-cell responses.

Authors:  Carsten B Schmidt-Weber; Steffen Kunzmann; Kurt Blaser
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

2.  Neogenin regulation of BMP-induced canonical Smad signaling and endochondral bone formation.

Authors:  Zheng Zhou; Jianxin Xie; Daehoon Lee; Yu Liu; Jiung Jung; Lijuan Zhou; Shan Xiong; Lin Mei; Wen-Cheng Xiong
Journal:  Dev Cell       Date:  2010-07-20       Impact factor: 12.270

3.  Inhibition of hepcidin transcription by growth factors.

Authors:  Julia B Goodnough; Emilio Ramos; Elizabeta Nemeth; Tomas Ganz
Journal:  Hepatology       Date:  2012-06-18       Impact factor: 17.425

4.  Inhibition of transforming growth factor-beta/Smad signaling by phosphatidylinositol 3-kinase pathway.

Authors:  Jingbo Qiao; Junghee Kang; Tien C Ko; B Mark Evers; Dai H Chung
Journal:  Cancer Lett       Date:  2006-01-18       Impact factor: 8.679

5.  The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer.

Authors:  Andres Rojas; Shereen Meherem; Young-Ho Kim; Mary Kay Washington; Joseph E Willis; Sanford D Markowitz; William M Grady
Journal:  Int J Cancer       Date:  2008-07-01       Impact factor: 7.396

6.  Epithelial and ectomesenchymal role of the type I TGF-beta receptor ALK5 during facial morphogenesis and palatal fusion.

Authors:  Marek Dudas; Jieun Kim; Wai-Yee Li; Andre Nagy; Jonas Larsson; Stefan Karlsson; Yang Chai; Vesa Kaartinen
Journal:  Dev Biol       Date:  2006-05-27       Impact factor: 3.582

7.  Expression profiling of transforming growth factor beta superfamily genes in developing orofacial tissue.

Authors:  Partha Mukhopadhyay; Robert M Greene; M Michele Pisano
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-07

8.  Cdh1-anaphase-promoting complex targets Skp2 for destruction in transforming growth factor beta-induced growth inhibition.

Authors:  Weijun Liu; George Wu; Wenqi Li; David Lobur; Yong Wan
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

9.  Transforming growth factors beta coordinate cartilage and tendon differentiation in the developing limb mesenchyme.

Authors:  Carlos I Lorda-Diez; Juan A Montero; Carmen Martinez-Cue; Juan A Garcia-Porrero; Juan M Hurle
Journal:  J Biol Chem       Date:  2009-08-28       Impact factor: 5.157

10.  Liver cancer-derived hepatitis C virus core proteins shift TGF-beta responses from tumor suppression to epithelial-mesenchymal transition.

Authors:  Serena Battaglia; Nassima Benzoubir; Soizic Nobilet; Pierre Charneau; Didier Samuel; Anna Linda Zignego; Azeddine Atfi; Christian Bréchot; Marie-Françoise Bourgeade
Journal:  PLoS One       Date:  2009-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.